Meclizine hydrochloride and Alendronate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meclizine hydrochloride (meclizine hydrochloride) and Alendronate sodium (alendronate sodium). Common drug interactions include alopecia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Meclizine hydrochloride and Alendronate sodium. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Meclizine hydrochloride?

Meclizine hydrochloride has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 2,380 Meclizine hydrochloride users. Check the latest studies of Meclizine hydrochloride.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.



On Jul, 06, 2026

39 people who take Meclizine hydrochloride and Alendronate sodium together, and have interactions are studied.

Meclizine hydrochloride and Alendronate sodium drug interactions.

What are the common drug interactions of Meclizine Hydrochloride and Alendronate Sodium, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Arthralgia (joint pain)
  4. Balance disorder
  5. Bedridden
  6. Blood pressure decreased
  7. Bone pain
  8. Cataract (clouding of the lens inside the eye)
  9. Catheter site related reaction
  10. Cellulitis (infection under the skin)

male:

  1. Anxiety
  2. Aortic dilatation
  3. Fatigue (feeling of tiredness)
  4. Femur fracture
  5. Fracture displacement
  6. Gastritis (inflammation of stomach)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Hypertension (high blood pressure)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the common drug interactions of Meclizine Hydrochloride and Alendronate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Chronic kidney disease
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Pain
  7. Renal failure (kidney dysfunction)
  8. Renal impairment (severely reduced kidney function)

50-59:

  1. Drug ineffective

60+:

  1. Respiratory tract infection
  2. Weight decreased
  3. Chest pain
  4. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  5. Cough
  6. Decreased appetite
  7. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Gastritis (inflammation of stomach)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 10.26%
  2. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 10.26%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.69%
  4. Pain: 3 people, 7.69%
  5. Multiple Myeloma (cancer of the plasma cells): 3 people, 7.69%
  6. High Blood Pressure: 3 people, 7.69%
  7. Drowsiness: 3 people, 7.69%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 7.69%
  9. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.13%
  10. Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Meclizine hydrochloride and Alendronate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Meclizine hydrochloride and Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meclizine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meclizine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alendronate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride and alendronate sodium (the active ingredients of Meclizine hydrochloride and Alendronate sodium, respectively), and Meclizine hydrochloride and Alendronate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: